China said on Wednesday three drugmakers had submitted applications to supply their COVID-19 vaccines to global vaccine-sharing scheme COVAX in the country’s first formal move to provide locally developed shots to the initiative.
For more coronavirus news, visit our dedicated page.
Sinovac Biotech, China National Pharmaceutical Group (Sinopharm) and CanSino Biologics have filed applications to join the scheme, China’s foreign ministry spokeswoman Hua Chunying told a news conference on Wednesday.
For all the latest headlines follow our Google News channel online or via the app
The COVAX scheme -- led by the World Health Organization and GAVI vaccine alliance -- is due to start rolling out vaccines to poor and middle-income countries in February, with 2 of 3 billion doses expected to be delivered this year.
Read more: Coronavirus: What we know about China's vaccine development, efficacy data, timelines
WHO Director-General Tedros Adhanom Ghebreyesus said on Monday that vaccine nationalism had put the world on the brink of “catastrophic moral failure,” and urged countries and manufacturers to spread doses more fairly around the world.
- Coronavirus: Pakistan approves China’s Sinopharm COVID-19 vaccine for emergency use
- Coronavirus: Indonesia approves China’s Sinovac vaccine amid COVID-19 surge
- Coronavirus: Jordan approves China’s Sinopharm COVID-19 vaccine
- Different efficacy data for China’s COVID-19 vaccine ‘real and valid’: Company
- Coronavirus: What we know about China's vaccine development, efficacy data, timelines
- China approves Sinopharm COVID-19 vaccine
- China Sinopharm’s vaccine 79 percent protective against COVID-19